Creating new hope and better patient insights through precision diagnostics and therapeutics

Portfolio Development Overview

2022

H1

H2

2023

H1

H2

2024

H1

H2

Dengue (mAb)

Pre-Clinical (in vitro)

Pre-Clinical (in vivo)

Clinical Trial (Phase I)

H2

Clinical Trial (Phase II)

Dengue (GENIE)

Prototype Development

Sales (Research Use Only)

Sales (Regulatory Approved)

COVID (Imtracker)

RUO Usage

Regulatory approvals

TB Therapeutic

Pre-Clinical (in vitro)

Portfolio Development Overview

pic15-01-scaled-1

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Massa, ac tristique erat sed porta. Cursus nam quam convallis enim erat id euismod. Blandit nam massa tempus,